To elucidate the pathways that regulate tumor-initiating Caco-2 cell growth and survival, we characterized the biological properties of CD44-CD133-, CD44-CD133+, and CD44+CD133+ subpopulations using in vitro and in vivo systems. The gene discussed is PROM1; the disease is neoplasm.